 | • レポートコード：D005-00957 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、皮下注射の世界市場を広く調査・分析し、今後の市場展望をまとめております。皮下注射の種類別市場規模（皮下注射用器具、皮下注射剤、その他）、用途別市場規模（病院、クリニック、検査室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Becton Dickinson、Takeda Pharmaceutical、Roche、Daiichi Sankyo、Asahi Kasei Pharma、Sanofi、Eisai Co.，Ltd、Eli Lilly、GSK、Antares Pharma, Inc.、Chugai Pharmaceutical、Aspen Medical Group、Endo International、PenJet Corporation ・地域別グローバル市場分析 2015年-2020年 ・皮下注射の北米市場（アメリカ、カナダ、メキシコ） ・皮下注射のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・皮下注射のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・皮下注射の南米市場（ブラジル、アルゼンチン） ・皮下注射の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：皮下注射用器具、皮下注射剤、その他 ・用途別分析：病院、クリニック、検査室、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Subcutaneous Injection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Subcutaneous Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Subcutaneous Injection market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Subcutaneous Injection market has been segmented into:
Subcutaneous Injection Equipment
Subcutaneous Injection Drug
Others
By Application, Subcutaneous Injection has been segmented into:
Hospital
Clinic
Laboratory
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Subcutaneous Injection market presented in the report. This section sheds light on the sales growth of different regional and country-level Subcutaneous Injection markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Subcutaneous Injection market.
The report offers in-depth assessment of the growth and other aspects of the Subcutaneous Injection market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Subcutaneous Injection Market Share Analysis
Subcutaneous Injection competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Subcutaneous Injection sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Subcutaneous Injection sales, revenue and market share for each player covered in this report.
The major players covered in Subcutaneous Injection are:
Becton Dickinson
Takeda Pharmaceutical
Roche
Daiichi Sankyo
Asahi Kasei Pharma
Sanofi
Eisai Co.，Ltd
Eli Lilly
GSK
Antares Pharma, Inc.
Chugai Pharmaceutical
Aspen Medical Group
Endo International
PenJet Corporation
Table of Contents
1 Subcutaneous Injection Market Overview
1.1 Product Overview and Scope of Subcutaneous Injection
1.2 Classification of Subcutaneous Injection by Type
1.2.1 Global Subcutaneous Injection Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Subcutaneous Injection Revenue Market Share by Type in 2019
1.2.3 Subcutaneous Injection Equipment
1.2.4 Subcutaneous Injection Drug
1.2.5 Others
1.3 Global Subcutaneous Injection Market by Application
1.3.1 Overview: Global Subcutaneous Injection Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Global Subcutaneous Injection Market by Regions
1.4.1 Global Subcutaneous Injection Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Subcutaneous Injection (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Subcutaneous Injection Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Subcutaneous Injection Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Subcutaneous Injection Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Subcutaneous Injection Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Subcutaneous Injection Status and Prospect (2015-2025)
2 Company Profiles
2.1 Becton Dickinson
2.1.1 Becton Dickinson Details
2.1.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Becton Dickinson SWOT Analysis
2.1.4 Becton Dickinson Product and Services
2.1.5 Becton Dickinson Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda Pharmaceutical
2.2.1 Takeda Pharmaceutical Details
2.2.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Takeda Pharmaceutical SWOT Analysis
2.2.4 Takeda Pharmaceutical Product and Services
2.2.5 Takeda Pharmaceutical Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.4 Daiichi Sankyo
2.4.1 Daiichi Sankyo Details
2.4.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Daiichi Sankyo SWOT Analysis
2.4.4 Daiichi Sankyo Product and Services
2.4.5 Daiichi Sankyo Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.5 Asahi Kasei Pharma
2.5.1 Asahi Kasei Pharma Details
2.5.2 Asahi Kasei Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Asahi Kasei Pharma SWOT Analysis
2.5.4 Asahi Kasei Pharma Product and Services
2.5.5 Asahi Kasei Pharma Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eisai Co.，Ltd
2.7.1 Eisai Co.，Ltd Details
2.7.2 Eisai Co.，Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eisai Co.，Ltd SWOT Analysis
2.7.4 Eisai Co.，Ltd Product and Services
2.7.5 Eisai Co.，Ltd Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GSK SWOT Analysis
2.9.4 GSK Product and Services
2.9.5 GSK Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.10 Antares Pharma, Inc.
2.10.1 Antares Pharma, Inc. Details
2.10.2 Antares Pharma, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Antares Pharma, Inc. SWOT Analysis
2.10.4 Antares Pharma, Inc. Product and Services
2.10.5 Antares Pharma, Inc. Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.11 Chugai Pharmaceutical
2.11.1 Chugai Pharmaceutical Details
2.11.2 Chugai Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Chugai Pharmaceutical SWOT Analysis
2.11.4 Chugai Pharmaceutical Product and Services
2.11.5 Chugai Pharmaceutical Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.12 Aspen Medical Group
2.12.1 Aspen Medical Group Details
2.12.2 Aspen Medical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Aspen Medical Group SWOT Analysis
2.12.4 Aspen Medical Group Product and Services
2.12.5 Aspen Medical Group Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.13 Endo International
2.13.1 Endo International Details
2.13.2 Endo International Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Endo International SWOT Analysis
2.13.4 Endo International Product and Services
2.13.5 Endo International Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
2.14 PenJet Corporation
2.14.1 PenJet Corporation Details
2.14.2 PenJet Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 PenJet Corporation SWOT Analysis
2.14.4 PenJet Corporation Product and Services
2.14.5 PenJet Corporation Subcutaneous Injection Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Subcutaneous Injection Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Subcutaneous Injection Players Market Share
3.2.2 Top 10 Subcutaneous Injection Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Subcutaneous Injection Revenue and Market Share by Regions
4.2 North America Subcutaneous Injection Revenue and Growth Rate (2015-2020)
4.3 Europe Subcutaneous Injection Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Subcutaneous Injection Revenue and Growth Rate (2015-2020)
4.5 South America Subcutaneous Injection Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Subcutaneous Injection Revenue and Growth Rate (2015-2020)
5 North America Subcutaneous Injection Revenue by Countries
5.1 North America Subcutaneous Injection Revenue by Countries (2015-2020)
5.2 USA Subcutaneous Injection Revenue and Growth Rate (2015-2020)
5.3 Canada Subcutaneous Injection Revenue and Growth Rate (2015-2020)
5.4 Mexico Subcutaneous Injection Revenue and Growth Rate (2015-2020)
6 Europe Subcutaneous Injection Revenue by Countries
6.1 Europe Subcutaneous Injection Revenue by Countries (2015-2020)
6.2 Germany Subcutaneous Injection Revenue and Growth Rate (2015-2020)
6.3 UK Subcutaneous Injection Revenue and Growth Rate (2015-2020)
6.4 France Subcutaneous Injection Revenue and Growth Rate (2015-2020)
6.5 Russia Subcutaneous Injection Revenue and Growth Rate (2015-2020)
6.6 Italy Subcutaneous Injection Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Subcutaneous Injection Revenue by Countries
7.1 Asia-Pacific Subcutaneous Injection Revenue by Countries (2015-2020)
7.2 China Subcutaneous Injection Revenue and Growth Rate (2015-2020)
7.3 Japan Subcutaneous Injection Revenue and Growth Rate (2015-2020)
7.4 Korea Subcutaneous Injection Revenue and Growth Rate (2015-2020)
7.5 India Subcutaneous Injection Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Subcutaneous Injection Revenue and Growth Rate (2015-2020)
8 South America Subcutaneous Injection Revenue by Countries
8.1 South America Subcutaneous Injection Revenue by Countries (2015-2020)
8.2 Brazil Subcutaneous Injection Revenue and Growth Rate (2015-2020)
8.3 Argentina Subcutaneous Injection Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Subcutaneous Injection by Countries
9.1 Middle East & Africa Subcutaneous Injection Revenue by Countries (2015-2020)
9.2 Saudi Arabia Subcutaneous Injection Revenue and Growth Rate (2015-2020)
9.3 UAE Subcutaneous Injection Revenue and Growth Rate (2015-2020)
9.4 Egypt Subcutaneous Injection Revenue and Growth Rate (2015-2020)
9.5 South Africa Subcutaneous Injection Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Subcutaneous Injection Revenue and Market Share by Type (2015-2020)
10.2 Global Subcutaneous Injection Market Forecast by Type (2019-2024)
10.3 Subcutaneous Injection Equipment Revenue Growth Rate (2015-2025)
10.4 Subcutaneous Injection Drug Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Subcutaneous Injection Market Segment by Application
11.1 Global Subcutaneous Injection Revenue Market Share by Application (2015-2020)
11.2 Subcutaneous Injection Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Laboratory Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Subcutaneous Injection Market Size Forecast (2021-2025)
12.1 Global Subcutaneous Injection Market Size Forecast (2021-2025)
12.2 Global Subcutaneous Injection Market Forecast by Regions (2021-2025)
12.3 North America Subcutaneous Injection Revenue Market Forecast (2021-2025)
12.4 Europe Subcutaneous Injection Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Subcutaneous Injection Revenue Market Forecast (2021-2025)
12.6 South America Subcutaneous Injection Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Subcutaneous Injection Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Subcutaneous Injection Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Subcutaneous Injection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Subcutaneous Injection Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Subcutaneous Injection Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Becton Dickinson Corporate Information, Location and Competitors
Table 6. Becton Dickinson Subcutaneous Injection Major Business
Table 7. Becton Dickinson Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 8. Becton Dickinson SWOT Analysis
Table 9. Becton Dickinson Subcutaneous Injection Product and Solutions
Table 10. Becton Dickinson Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Takeda Pharmaceutical Corporate Information, Location and Competitors
Table 12. Takeda Pharmaceutical Subcutaneous Injection Major Business
Table 13. Takeda Pharmaceutical Subcutaneous Injection Total Revenue (USD Million) (2018-2019)
Table 14. Takeda Pharmaceutical SWOT Analysis
Table 15. Takeda Pharmaceutical Subcutaneous Injection Product and Solutions
Table 16. Takeda Pharmaceutical Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Roche Corporate Information, Location and Competitors
Table 18. Roche Subcutaneous Injection Major Business
Table 19. Roche Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 20. Roche SWOT Analysis
Table 21. Roche Subcutaneous Injection Product and Solutions
Table 22. Roche Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Daiichi Sankyo Corporate Information, Location and Competitors
Table 24. Daiichi Sankyo Subcutaneous Injection Major Business
Table 25. Daiichi Sankyo Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 26. Daiichi Sankyo SWOT Analysis
Table 27. Daiichi Sankyo Subcutaneous Injection Product and Solutions
Table 28. Daiichi Sankyo Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Asahi Kasei Pharma Corporate Information, Location and Competitors
Table 30. Asahi Kasei Pharma Subcutaneous Injection Major Business
Table 31. Asahi Kasei Pharma Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 32. Asahi Kasei Pharma SWOT Analysis
Table 33. Asahi Kasei Pharma Subcutaneous Injection Product and Solutions
Table 34. Asahi Kasei Pharma Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sanofi Corporate Information, Location and Competitors
Table 36. Sanofi Subcutaneous Injection Major Business
Table 37. Sanofi Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 38. Sanofi SWOT Analysis
Table 39. Sanofi Subcutaneous Injection Product and Solutions
Table 40. Sanofi Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Eisai Co.，Ltd Corporate Information, Location and Competitors
Table 42. Eisai Co.，Ltd Subcutaneous Injection Major Business
Table 43. Eisai Co.，Ltd Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 44. Eisai Co.，Ltd SWOT Analysis
Table 45. Eisai Co.，Ltd Subcutaneous Injection Product and Solutions
Table 46. Eisai Co.，Ltd Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Eli Lilly Corporate Information, Location and Competitors
Table 48. Eli Lilly Subcutaneous Injection Major Business
Table 49. Eli Lilly Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 50. Eli Lilly SWOT Analysis
Table 51. Eli Lilly Subcutaneous Injection Product and Solutions
Table 52. Eli Lilly Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GSK Corporate Information, Location and Competitors
Table 54. GSK Subcutaneous Injection Major Business
Table 55. GSK Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 56. GSK SWOT Analysis
Table 57. GSK Subcutaneous Injection Product and Solutions
Table 58. GSK Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Antares Pharma, Inc. Corporate Information, Location and Competitors
Table 60. Antares Pharma, Inc. Subcutaneous Injection Major Business
Table 61. Antares Pharma, Inc. Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 62. Antares Pharma, Inc. SWOT Analysis
Table 63. Antares Pharma, Inc. Subcutaneous Injection Product and Solutions
Table 64. Antares Pharma, Inc. Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Chugai Pharmaceutical Corporate Information, Location and Competitors
Table 66. Chugai Pharmaceutical Subcutaneous Injection Major Business
Table 67. Chugai Pharmaceutical Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 68. Chugai Pharmaceutical SWOT Analysis
Table 69. Chugai Pharmaceutical Subcutaneous Injection Product and Solutions
Table 70. Chugai Pharmaceutical Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Aspen Medical Group Corporate Information, Location and Competitors
Table 72. Aspen Medical Group Subcutaneous Injection Major Business
Table 73. Aspen Medical Group Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 74. Aspen Medical Group SWOT Analysis
Table 75. Aspen Medical Group Subcutaneous Injection Product and Solutions
Table 76. Aspen Medical Group Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Endo International Corporate Information, Location and Competitors
Table 78. Endo International Subcutaneous Injection Major Business
Table 79. Endo International Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 80. Endo International SWOT Analysis
Table 81. Endo International Subcutaneous Injection Product and Solutions
Table 82. Endo International Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. PenJet Corporation Corporate Information, Location and Competitors
Table 84. PenJet Corporation Subcutaneous Injection Major Business
Table 85. PenJet Corporation Subcutaneous Injection Total Revenue (USD Million) (2017-2018)
Table 86. PenJet Corporation SWOT Analysis
Table 87. PenJet Corporation Subcutaneous Injection Product and Solutions
Table 88. PenJet Corporation Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Subcutaneous Injection Revenue (Million USD) by Players (2015-2020)
Table 90. Global Subcutaneous Injection Revenue Share by Players (2015-2020)
Table 91. Global Subcutaneous Injection Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Subcutaneous Injection Revenue Market Share by Regions (2015-2020)
Table 93. North America Subcutaneous Injection Revenue by Countries (2015-2020)
Table 94. North America Subcutaneous Injection Revenue Market Share by Countries (2015-2020)
Table 95. Europe Subcutaneous Injection Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Subcutaneous Injection Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Subcutaneous Injection Revenue by Countries (2015-2020)
Table 98. South America Subcutaneous Injection Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Subcutaneous Injection Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Subcutaneous Injection Revenue Market Share by Countries (2015-2020)
Table 101. Global Subcutaneous Injection Revenue (Million USD) by Type (2015-2020)
Table 102. Global Subcutaneous Injection Revenue Share by Type (2015-2020)
Table 103. Global Subcutaneous Injection Revenue Forecast by Type (2021-2025)
Table 104. Global Subcutaneous Injection Revenue by Application (2015-2020)
Table 105. Global Subcutaneous Injection Revenue Share by Application (2015-2020)
Table 106. Global Subcutaneous Injection Revenue Forecast by Application (2021-2025)
Table 107. Global Subcutaneous Injection Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Subcutaneous Injection Picture
Figure 2. Global Subcutaneous Injection Revenue Market Share by Type in 2019
Figure 3. Subcutaneous Injection Equipment Picture
Figure 4. Subcutaneous Injection Drug Picture
Figure 5. Others Picture
Figure 6. Subcutaneous Injection Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Laboratory Picture
Figure 10. Others Picture
Figure 11. Global Subcutaneous Injection Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Subcutaneous Injection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Subcutaneous Injection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Subcutaneous Injection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Subcutaneous Injection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Subcutaneous Injection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Subcutaneous Injection Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Subcutaneous Injection Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Subcutaneous Injection Revenue Market Share in 2019
Figure 20. Global Top 10 Players Subcutaneous Injection Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Subcutaneous Injection Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Subcutaneous Injection Revenue Market Share by Regions (2015-2020)
Figure 24. Global Subcutaneous Injection Revenue Market Share by Regions in 2018
Figure 25. North America Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 26. Europe Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 28. South America Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 30. North America Subcutaneous Injection Revenue Market Share by Countries (2015-2020)
Figure 31. North America Subcutaneous Injection Revenue Market Share by Countries in 2019
Figure 32. USA Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 33. Canada Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 35. Europe Subcutaneous Injection Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Subcutaneous Injection Revenue Market Share by Countries in 2019
Figure 37. Germany Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 38. UK Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 39. France Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 40. Russia Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 41. Italy Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Subcutaneous Injection Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Subcutaneous Injection Revenue Market Share by Countries in 2019
Figure 44. China Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 45. Japan Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 46. Korea Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 47. India Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 49. South America Subcutaneous Injection Revenue Market Share by Countries (2015-2020)
Figure 50. South America Subcutaneous Injection Revenue Market Share by Countries in 2019
Figure 51. Brazil Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Subcutaneous Injection Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Subcutaneous Injection Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 56. UAE Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Subcutaneous Injection Revenue and Growth Rate (2015-2020)
Figure 59. Global Subcutaneous Injection Revenue Share by Type (2015-2020)
Figure 60. Global Subcutaneous Injection Revenue Share by Type in 2019
Figure 61. Global Subcutaneous Injection Market Share Forecast by Type (2021-2025)
Figure 62. Global Subcutaneous Injection Equipment Revenue Growth Rate (2015-2020)
Figure 63. Global Subcutaneous Injection Drug Revenue Growth Rate (2015-2020)
Figure 64. Global Others Revenue Growth Rate (2015-2020)
Figure 65. Global Subcutaneous Injection Revenue Share by Application (2015-2020)
Figure 66. Global Subcutaneous Injection Revenue Share by Application in 2019
Figure 67. Global Subcutaneous Injection Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospital Revenue Growth Rate (2015-2020)
Figure 69. Global Clinic Revenue Growth Rate (2015-2020)
Figure 70. Global Laboratory Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Subcutaneous Injection Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Subcutaneous Injection Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Subcutaneous Injection Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Subcutaneous Injection Revenue Market Forecast (2021-2025)
Figure 76. Europe Subcutaneous Injection Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Subcutaneous Injection Revenue Market Forecast (2021-2025)
Figure 78. South America Subcutaneous Injection Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Subcutaneous Injection Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
皮下注射器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Subcutaneous Injector market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Subcutaneous Injector m…- 注射用マムシ由来凝血促進剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Haemocoagulase Agkistrodon for Injection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Haem…
- 腫瘍用注射薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oncology Injection Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncology Injection Dr…
- 自動車用ガソリン直接噴射（GDI）システムの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Automotive Gasoline Direct Injection (GDI) Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019…
- スルファジアジンナトリウム注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sulfadiazine Sodium Injection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sulfadiazine So…